| Inflammatory breast cancer promotes development of M2 tumor-associated macrophages and cancer mesenchymal cells through a complex chemokine network A Valeta-Magara, A Gadi, V Volta, B Walters, R Arju, S Giashuddin, ... Cancer research 79 (13), 3360-3371, 2019 | 113 | 2019 |
| Nuclear cysteine cathepsin variants in thyroid carcinoma cells S Tedelind, K Poliakova, A Valeta, R Hunegnaw, EL Yemanaberhan, ... Walter de Gruyter 391 (8), 923-935, 2010 | 82 | 2010 |
| Hyperactivated mTOR and JAK2/STAT3 pathways: molecular drivers and potential therapeutic targets of inflammatory and invasive ductal breast cancers after neoadjuvant chemotherapy K Jhaveri, E Teplinsky, D Silvera, A Valeta-Magara, R Arju, S Giashuddin, ... Clinical breast cancer 16 (2), 113-122. e1, 2016 | 57 | 2016 |
| Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions A Valeta-Magara, R Hatami, D Axelrod, DF Roses, A Guth, SC Formenti, ... SpringerPlus 4, 1-11, 2015 | 13 | 2015 |
| Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC). E Teplinsky, A Valeta, R Arju, S Giashuddin, Y Sarfraz, M Alexander, ... Journal of Clinical Oncology 31 (no. 26_suppl), 60-60, 2013 | 2* | 2013 |
| Art1, an extracellular mono-ADP-ribosyltransferase, is upregulated in response to cellular stress and promotes lung cancer growth S Mukherjee, E Wennerberg, C Hung, N Saadallah, S Kariyawasam, ... Cancer Research 80 (16_Supplement), 1820-1820, 2020 | 1 | 2020 |
| MTOR inhibition favors the differentiation of human in vitro-induced regulatory T cell through selective protein synthesis V Volta, A Ernlund, A Valeta, S Demaria, RJ Schneider Journal for ImmunoTherapy of Cancer 3 (Suppl 2), 2015 | 1 | 2015 |
| mTOR inhibition promotes differentiation of human regulatory T cells via privileged mRNA translation V Volta, A Ernlund, A Gadi, A Valeta-Magara, C de la Parra, P Patel, ... MOLECULAR CANCER RESEARCH 18 (10), 40-40, 2020 | | 2020 |
| Abstract A26: mTOR inhibition promotes differentiation of human regulatory T cells via privileged mRNA translation V Volta, A Ernlund, A Gadi, A Valeta-Magara, C de la Parra, P Patel, ... Molecular Cancer Research 18 (10_Supplement), A26-A26, 2020 | | 2020 |
| ART1 tumor expression mediates immune resistance in non-small cell lung cancer by elimination of P2× 7R+ CD8 tissue resident memory T cells and conventional type I dendritic cells E Wennerberg, C Hung, A Valeta, T McGraw, S Demaria, B Stiles Cancer Research 80 (16_Supplement), 2158-2158, 2020 | | 2020 |
| Expression of ART1, an extracellular mono ADP-ribosylase, promotes lung cancer growth and dissemination by limiting tumor infiltration of P2X7R+ CD8+ T cells and CD103+ … E Wennerberg, C Hung, A Valeta, T McGraw, S Demaria, B Stiles JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| Abstract A222: Exploiting mTORC1-independent protein synthesis in Tregs to boost antitumor immune response V Volta, A Ernlund, CD Parra, A Gadi, A Valeta-Magara, RJ Schneider Cancer Immunology Research 7 (2_Supplement), A222-A222, 2019 | | 2019 |
| Abstract PD5-6: Sustained hyperactivated mTOR & JAK2/STAT3 pathways in inflammatory breast cancer (IBC): Evidence for mTOR plus JAK2 therapeutic targeting K Jhaveri, E Teplinsky, R Arzu, S Giashuddin, Y Sarfraz, M Alexander, ... Cancer Research 73 (24_Supplement), PD5-6-PD5-6, 2013 | | 2013 |
| ART1 tumor expression mediates immune resistance in non-small cell lung cancer by elimination of tumor-infiltrating P2X7R+ CD8 T cells and conventional type I dendritic cells E Wennerberg, S Mukherjee, C Hung, A Valeta, T McGraw, S Demaria, ... | | |
